Losartan Potassium and Hydrochlorothiazide
- Product NDC
- 70518-2564
- 11-digit product format
- 705182564
- Labeler code
- 70518
- Product ID
- 70518-2564_dc288c1e-cee8-18ac-e053-2995a90ac480
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Losartan Potassium and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA078245
- Marketing category
- ANDA
- Marketing start
- 2020-02-04
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2564-0 | 70518256400 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-2564-0) | 90 tablet | 2020-02-04 | 0000-00-00 | No | No | Current |